Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

NCT01111318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency
Healthy

Interventions

DRUG: BI 10773

Sponsor

Boehringer Ingelheim